))
Episode 3: Opeyemi Olabisi on APOL1-Mediated Kidney Disease and Community Engagement
Manage episode 394837053 series 3507852
Content provided by International Society of Glomerular Disease. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by International Society of Glomerular Disease or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
We talk with Dr. Opeyemi Olabisi, MD, PhD, about the history and future of APOL1-mediated FSGS, the role of clinical researchers in building trust with patients, his innovative CARE and JUSTICE programs to bring kidney health screenings and research opportunities to the underrepresented African American community, and why his expertise as an MD/PhD in molecular biology led him to also become a leader in community engagement. The JAK-STAT pathway gets some love as well!
Dr. Olabisi's research and publications: https://medicine.duke.edu/profile/opeyemi-olabisi
More information on the CARE and JUSTICE studies: https://kidneycareandjustice.com/
Disclosures: Dr. Olabisi reports receiving research funding from NIH and Icagen, and consulting for Maze Therapeutics and Podium Bio.
8 episodes
Share
